Arthritis
Bimekizumab sustains positive results in new, long-term data for psoriatic arthritis
UCB announced new long-term data from BE COMPLETE’s 52-week open label extension evaluating the efficacy and safety of bimekizumab in adults with active psoriatic arthritis, according to a press release.
Depression lowers pain threshold in psoriatic arthritis patients
Patients with psoriatic arthritis who suffer from depression may experience higher levels of pain despite having similar amounts of inflammation as those without depression.
Patients with knee, hip OA who exercise frequently demonstrate improved long-term function
Patients with hip or knee osteoarthritis who report frequent physical activity demonstrate improved health-related quality of life and physical function over a period of 5 years, according to data published in Arthritis Care & Research.
Rheumatoid arthritis may be strong driver for incident HF
Rheumatoid arthritis is independently associated with incident HF across the range of ejection fraction, with a stronger association among those with an EF of at least 40%, researchers reported.
Top in rheumatology: Adalimumab biosimilar approval; the immunopathophysiology of PsA
The FDA approved Idacio as a biosimilar to Humira, a TNF inhibitor with indications for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis and plaque psoriasis.
Bimekizumab meets primary, ranked secondary endpoints in two psoriatic arthritis studies
Adults with active psoriatic arthritis taking bimekizumab saw significant improvements in joint symptoms and skin clearance compared with those taking placebo, UCB announced in a press release.
Video: How PCPs should approach new rheumatoid arthritis guidelines
New guidance from the American College of Rheumatology strongly recommends that patients with rheumatoid arthritis engage in physical exercise when possible.
Pre-arthritis methotrexate use improves RA course, fails to prevent clinical arthritis
Methotrexate use at the pre-arthritis stage of symptoms and subclinical inflammation fails to prevent clinical arthritis, but does improve symptoms and MRI-detected inflammation vs. placebo, according to data published in The Lancet.
Speaker: Sutures, implants may improve current treatments
CHICAGO — New techniques and implants to treat carpometacarpal arthritis may soon take the place of ligament reconstruction with tendon interposition for this indication, providing better pinch strength and other benefits, a speaker said.
Benefits of statins ‘outweigh’ increased diabetes risk in rheumatoid arthritis
The benefits of statins in reducing cardiovascular disease and mortality “outweigh” the associated increased risk for type 2 diabetes in patients with rheumatoid arthritis, according to data published in Arthritis Care & Research.